Financial Performance - The company's operating revenue for Q1 2025 was CNY 401,995,270.58, representing a 19.78% increase compared to CNY 335,623,155.40 in the same period last year[4] - Net profit attributable to shareholders was CNY 119,417,662.41, a 45.30% increase from CNY 82,184,172.26 year-over-year[4] - The net profit after deducting non-recurring gains and losses was CNY 112,987,049.26, reflecting a 37.51% increase compared to CNY 82,167,819.58 in the previous year[4] - Basic earnings per share increased by 50.00% to CNY 0.30 from CNY 0.20 in the previous year[4] - Diluted earnings per share also rose by 50.00%, reaching CNY 0.30 compared to CNY 0.20 last year[5] - Total operating revenue for Q1 2025 reached ¥401,995,270.58, a 19.7% increase from ¥335,623,155.40 in Q1 2024[18] - Net profit for Q1 2025 was ¥119,417,662.41, representing a 45.3% increase compared to ¥82,184,172.26 in Q1 2024[19] - Basic and diluted earnings per share for Q1 2025 were both ¥0.30, up from ¥0.20 in Q1 2024[20] - The company reported a total profit of ¥141,535,689.38 for Q1 2025, up from ¥99,108,144.14 in Q1 2024[19] Cash Flow - The net cash flow from operating activities decreased by 71.26%, amounting to CNY 25,705,558.93, down from CNY 89,426,909.65 in the same period last year[4] - Operating cash inflow totaled $397,906,535.95, an increase from $384,208,482.52 year-over-year[23] - Operating cash outflow amounted to $372,200,977.02, compared to $294,781,572.87 in the previous period[23] - Net cash flow from operating activities was $25,705,558.93, down from $89,426,909.65 year-over-year[23] - Cash inflow from investment activities reached $269,306,482.21, significantly higher than $539,851.53 in the prior period[23] - Cash outflow from investment activities was $332,502,382.62, compared to $140,559,046.91 previously[23] - Net cash flow from investment activities was -$63,195,900.41, an improvement from -$140,019,195.38 year-over-year[23] - Cash inflow from financing activities totaled $63,127,400.00, down from $134,514,228.46[24] - Cash outflow from financing activities was $60,151,348.75, compared to $102,191,356.54 in the previous period[24] - Net cash flow from financing activities was $2,976,051.25, a decrease from $32,322,871.92 year-over-year[24] - The ending cash and cash equivalents balance was $736,602,666.87, up from $400,661,672.44 in the prior period[24] Assets and Liabilities - The total assets at the end of the reporting period were CNY 3,897,048,240.76, a slight increase of 0.51% from CNY 3,877,422,385.61 at the end of the previous year[5] - The equity attributable to shareholders increased by 4.68% to CNY 2,440,575,900.00 from CNY 2,331,528,721.53 at the end of the previous year[5] - The company's total liabilities decreased to RMB 1,456,472,340.76 from RMB 1,545,893,664.08, reflecting a decrease of approximately 5.8%[14] - Current liabilities decreased to RMB 437,873,952.97 from RMB 532,037,038.75, a reduction of about 17.7%[14] - Non-current assets totaled RMB 1,874,767,784.63, up from RMB 1,830,626,381.82, marking an increase of about 2.4%[13][14] - The company reported a significant increase in fixed assets, which rose to RMB 776,502,004.08 from RMB 606,807,832.86, an increase of approximately 28%[13] - Cash and cash equivalents decreased to RMB 736,602,666.87 from RMB 769,439,830.87, reflecting a decline of approximately 4.8%[12] - Accounts receivable increased to RMB 393,092,250.58 from RMB 349,757,854.06, representing an increase of about 12.4%[13] - Inventory rose to RMB 614,823,371.98 from RMB 589,721,953.58, indicating an increase of approximately 4.3%[13] Non-Recurring Items - Non-recurring gains and losses amounted to CNY 6,430,613.15, with government subsidies contributing CNY 4,178,427.58[6] - Other comprehensive income for Q1 2025 was -¥32,591.37, compared to ¥34,431.97 in Q1 2024[20] Shareholder Information - The company has no significant changes in the top 10 shareholders or their participation in margin trading[11] - There are no new strategies or major product developments mentioned in the conference call[11] Research and Development - Research and development expenses for Q1 2025 were ¥32,087,224.10, compared to ¥28,932,083.97 in Q1 2024, reflecting a 10.4% increase[19]
奥锐特(605116) - 2025 Q1 - 季度财报